StonvexLoading…
StonvexStonvexStonvexCore line items from IDT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-01-31 | Q4 2025 2025-10-31 | Annual 2025 2025-07-31 | Q2 2025 2025-04-30 |
|---|---|---|---|---|
Revenue | $643.27M | $322.75M | $1.23B | $914.90M |
Operating Income | $58.17M | $30.93M | $100.42M | $78.54M |
Net Income | $43.31M | $22.36M | $76.09M | $59.21M |
EPS (Diluted) | $1.72 | $0.89 | $3.01 | $2.34 |
Total Assets | $678.29M | $654.91M | $626.20M | $600.91M |
Total Liabilities | $310.09M | $307.25M | $295.79M | $290.06M |
Cash & Equivalents | $210.18M | $189.27M | $226.50M | $199.95M |
Free Cash Flow OCF − CapEx | $16.21M | $-15.96M | $106.29M | $80.55M |
Shares Outstanding | 25.12M | 25.19M | 25.30M | 25.31M |